2007-: Habilitation à diriger les recherches en Science (HDR), University of Paris 7.
1997: Ph.D. (Microbiology-Molecular virology) University of Paris 6.
Research and management
2013-: Head biology dpt, Ecole Normale Supérieure de Lyon.
2012-: board of directors, CIRI U1111
2012-: In charge of Biology at CNAM Rhône Alpes
2009-: team leader INSERM U758 (currently U1111)
2008-: Professor (2ème then 1ere classe) Ecole Normale Supérieure de Lyon.
2006-2010: Adjunct Associate Professor of Biochemistry and Molecular Biology, George Washington University, Washington DC, USA.
2001-2008: INSERM Research associate (CR2 then CR1), Unité d'Epidémiologie et Physiopathologie des Virus Oncogènes URA3015, Institut Pasteur, Paris.
2000-2001: post-doctoral fellow, unité d'oncologie virale, Institut Pasteur, Paris.
1997-2000: post-doctoral fellow, National Cancer Institute, NIH, USA
- ANR microbiology panel (2013-)
- FNRS (Belgium, 2010-)
- INSERM CSS5 (2007-2012)
- ANRS CSS2 (2007-2012)
- Retrovirology, Journal of Virology, PlosOne
- Sézary prize (French academy of medicine)
Our main objectives are to understand the physiopathology of the Human T cell Leukemia Virus Type 1 (HTLV-1) infection and to develop new regimen that could either prevent the occurence of Adult T cell Leukemia or that would allow patients treatmentTo achieve this goal, we take advantage of our combined expertise, of several in vitro or in vivo models that are available in the team. We also benefit from ongoing collaborations with epidemiologists, biochemists, and chemists.
Main organisms with whom the team collaborates : INSERM, Pasteur Institute, Necker Hospital, CNRS, NIH, George Mason university